Explore

Bipartisan Lawmakers Reintroduce Bill to Address High Heart Disease Risk in South Asian Americans

Bipartisan Lawmakers Reintroduce Bill to Address High Heart Disease Risk in South Asian Americans

A bipartisan group of U.S. lawmakers has reintroduced the South Asian Heart Health Awareness and Research Act. This legislation aims to increase federal research, public awareness, and culturally appropriate programs to address the disproportionately high incidence of heart disease among South Asian Americans. Representatives Pramila Jayapal and Joe Wilson, along with Senator Cory Booker, introduced the bill. The measure would authorize the U.S. health secretary to provide grants to states for programs focusing on communities severely affected by cardiovascular disease. The bill also seeks to ensure that research funding is directed towards risk factors that have not received adequate attention. South Asians in the United States face four times the risk of heart disease compared to the general population, with nearly two-thirds of middle-aged South Asian Americans facing an intermediate or high risk of heart failure within the next decade. The legislation is co-sponsored by Representatives Nanette Barragan...

Florida International University Researchers Discover New Compound for Antibiotic Development

Florida International University Researchers Discover New Compound for Antibiotic Development

Researchers at Florida International University (FIU), led by biochemistry professor Fenfei Leng, have developed a new high-throughput screening method to identify compounds that can target bacterial DNA gyrase, an enzyme essential for bacterial survival. While testing this method, they discovered Pyr-AMC, a previously unrecognized compound. This discovery, published in Nucleic Acids Research, offers a potential starting point for developing new antibiotics to combat growing antibiotic resistance. Pyr-AMC works by trapping DNA gyrase while it cuts DNA strands, preventing the bacteria from repairing the damage and ultimately leading to bacterial cell death. This mechanism is similar to that of fluoroquinolones, a class of antibiotics that also target DNA gyrase but to which bacteria have increasingly developed resistance. The new screening method allows for the rapid identification of rare gyrase poisons from large libraries of compounds.

UNC Lineberger Hosts High School Students to Promote Cancer Research Careers

UNC Lineberger Hosts High School Students to Promote Cancer Research Careers

Thirty-five students from the Academy of Biomedical Sciences at Southeast Raleigh Magnet High School recently visited the UNC Lineberger Comprehensive Cancer Center for a half-day program. Organized by UNC Lineberger’s Cancer Research Training and Education Coordination (CRTEC) program, the event aimed to expose students to various career paths within cancer research, ranging from lab science to research operations. The program included panel discussions, guided lab tours, and hands-on learning experiences. Students toured the labs of Blossom Damania, PhD; Jason Merker, MD, PhD; and Jen Jen Yeh, MD, and participated in a pathology demonstration led by Staci Keene, MD. Faculty members, including Matt Milowsky, MD; Philip Spanheimer, MD; William A. Wood, MD; Kirsten Bryant, PhD; Joanna Kovalski, PhD; Brian Strahl, PhD; and Tigist Tamir, PhD, led discussions on clinical and basic science research. The event concluded with a research careers panel featuring Ivy Adderley, Teresa Green, PhD, and Erica Moore, BSN...

Protein Restriction Research Highlights FGF21 Hormone's Role in Longevity and Metabolism

Protein Restriction Research Highlights FGF21 Hormone's Role in Longevity and Metabolism

Recent livestock research, as covered by Science Daily, indicates that restricting dietary protein can significantly impact longevity and metabolic health, primarily through the hormone FGF21 (fibroblast growth factor 21). When protein intake decreases, the liver produces more FGF21, which in turn can increase energy expenditure, improve blood sugar regulation, and reduce inflammation. This hormone acts as an endocrine signal, linking the liver and brain to regulate metabolism and feeding behavior during periods of protein restriction. The body appears to interpret protein availability as crucial information, with FGF21 signaling a coordinated response that alters appetite, energy use, growth, and overall metabolism. This effect has been observed across various animal species, and researchers are exploring whether this coordinated response explains the striking longevity effects seen in laboratory animals. The research challenges the notion that more protein is always better, suggesting a complex interplay...

Stratified Medicine Advances with AI and Genomic Technologies for Personalized Treatment

Stratified Medicine Advances with AI and Genomic Technologies for Personalized Treatment

Stratified medicine, also known as precision medicine, is evolving rapidly through the integration of artificial intelligence (AI) and genomic technologies. This approach focuses on customizing medical treatment for individual patients by utilizing biomarkers to identify specific subgroups within a diagnosis. The advancements allow for more targeted and effective therapies. AI and genomic technologies are enhancing the analysis of complex multimodal data, which includes imaging, physiological signals, and electronic health records. This comprehensive data analysis supports earlier diagnosis, more refined phenotyping, and improved risk stratification across various medical conditions. High-throughput pluripotent stem cell models combined with AI modeling are accelerating the development of precision medicine, particularly in fields such as oncology, neurodevelopmental and neurodegenerative disorders, and metabolic diseases. This shift moves away from a one-size-fits-all medical approach towards treatments t...

University of Texas MD Anderson Cancer Center Identifies B Cells as Key in Immunotherapy-Related Colitis

University of Texas MD Anderson Cancer Center Identifies B Cells as Key in Immunotherapy-Related Colitis

Researchers at The University of Texas MD Anderson Cancer Center have uncovered a significant role for B cells in the development and persistence of colitis, a severe side effect of immune checkpoint inhibitors used in cancer treatment. The study, published in Cell Reports, was led by Roza Nurieva, Ph.D., professor of Immunology. The findings indicate that changes in circulating B cell activity can occur before patients experience any symptoms, suggesting B cells could serve as a predictive biomarker for the risk of immunotherapy-related colitis. Immune checkpoint inhibitors have revolutionized cancer treatment by enhancing the immune system's ability to fight cancer, but they can also trigger severe immune-related adverse events, including colitis, which causes inflammation of the colon, severe diarrhea, abdominal pain, and intestinal bleeding. The study found that higher levels of B cells before treatment were associated with an increased risk of colitis, and preclinical models showed that B cell activat...

Israeli and U.S. Researchers Unravel 340-Year Mystery of Sweden's Queen Christina's Death

Israeli and U.S. Researchers Unravel 340-Year Mystery of Sweden's Queen Christina's Death

An international team of researchers, including Prof. Zaid Abassi from Technion in Israel and Prof. Rolf Barth of Ohio State University, along with Prof. L. Maximilian Buja of the University of Texas, has re-examined historical records to determine the cause of death of Queen Christina of Sweden, who died in 1689. Their analysis suggests that Queen Christina likely suffered from undiagnosed diabetes, which contributed to a chronic leg wound and subsequent bacterial infection. This infection is believed to have spread, leading to sepsis, which ultimately caused her death at age 62. The researchers reviewed symptoms documented during her lifetime, such as extreme thirst, excessive urination, weight loss, and chronic leg wounds, all consistent with diabetes. They also analyzed findings from her postmortem examination, which, despite a three-day delay, provided crucial clues, particularly regarding a recurring red lesion on her right leg diagnosed as erysipelas, a bacterial skin infection that can lead to seps...

Uterine Cancer Incidence and Mortality Rise, Exposing Deep Racial Disparities in the U.S.

Uterine Cancer Incidence and Mortality Rise, Exposing Deep Racial Disparities in the U.S.

Uterine cancer incidence and mortality are on the rise in the United States, making it the leading cause of death among gynecologic cancers, projected to surpass ovarian cancer in 2026. Despite overall declines in cancer mortality due to advances in prevention and treatment, uterine cancer stands as a notable exception. Elizabeth M. Swisher, MD, Chair of the AACR Cancer Prevention Working Group steering committee, highlights significant racial disparities, with Black women more likely to die from uterine cancer despite a lower overall incidence. This increased mortality among Black women is primarily driven by a higher prevalence of aggressive histologic subtypes, such as uterine serous carcinoma, carcinosarcoma, and clear cell carcinoma, which have higher mortality rates than other types. Swisher suggests that a combination of biological, economic, healthcare-related, and environmental factors contribute to these disparities, noting that Caribbean-born Black women have a lower risk of endometrial cancer t...

Lawmakers Reintroduce Bill to Address Fourfold Heart Disease Risk in South Asian Americans

Lawmakers Reintroduce Bill to Address Fourfold Heart Disease Risk in South Asian Americans

U.S. Representatives Pramila Jayapal (D-Wash.) and Joe Wilson (R-S.C.), along with Senator Cory Booker (D-N.J.), have reintroduced bipartisan legislation known as the South Asian Heart Health Awareness and Research Act. This bill aims to increase awareness, expand research, and strengthen prevention efforts for heart disease within the South Asian American community. Studies indicate that South Asians in the U.S., including immigrants from countries like India, Pakistan, Bangladesh, Sri Lanka, and Nepal, face a fourfold higher risk of heart disease compared to the general population. The legislation would authorize the Department of Health and Human Services (HHS) to provide grants to states. These grants would fund culturally appropriate materials on nutrition, diet, and exercise, support community-run heart health programs, and finance conferences and workshops to improve research practices and include disproportionately affected communities in scientific studies. The bill also mandates the HHS secretary...

Tempus AI Postdoctoral Fellow Position Opens in Precision Oncology Research

Tempus AI Postdoctoral Fellow Position Opens in Precision Oncology Research

Tempus AI, a technology company specializing in precision medicine, has announced an opening for a Postdoctoral Fellow in Chicago. This full-time, onsite research position is focused on advancing precision oncology through the application of computational methods to large-scale clinical and genomic cancer data. The successful candidate will have direct access to over 300,000 de-identified samples containing genomic and clinical data, a substantial organoid repository with genomic and pharmacological screening data, and a robust computational environment. The role involves mentorship and collaboration with clinicians, molecular biologists, and data scientists. Applicants are expected to possess a PhD in Computational Biology, Bioinformatics, or a related field, or an MD with extensive experience in clinical and translational cancer research, along with a strong record of scientific accomplishments.

Senator Schatz Advocates for Increased Cancer Research Funding and Clinical Trial Modernization Act

Senator Schatz Advocates for Increased Cancer Research Funding and Clinical Trial Modernization Act

U.S. Senator Brian Schatz (D-HI) recently met with cancer survivors and advocates in Washington, D.C., to push for increased federal funding for cancer research and prevention programs. A key focus of these discussions was the Clinical Trial Modernization Act. This proposed legislation aims to eliminate financial barriers that currently prevent many individuals, particularly those from underrepresented groups and rural areas, from participating in clinical trials. Michelle Lavarre, a cancer survivor from Kaua'i, was among the advocates who shared personal experiences and professional insights with Senator Schatz and other federal lawmakers, including U.S. Rep. Ed Case. Their collective effort is part of a broader initiative, the annual Leadership Summit and Lobby Day sponsored by the American Cancer Society Cancer Action Network, which brought together approximately 800 cancer patients, survivors, and advocates to engage with policymakers.

U.S. Researchers Contribute to Solving 340-Year Mystery of Queen Christina of Sweden's Death

U.S. Researchers Contribute to Solving 340-Year Mystery of Queen Christina of Sweden's Death

Professor Zaid Abassi of Technion, along with Professor Rolf Barth of Ohio State University and Professor L. Maximilian Buja of the University of Texas, have re-examined historical records and autopsy reports to shed new light on the death of Queen Christina of Sweden. Their research suggests that Queen Christina likely suffered from undiagnosed diabetes, which contributed to a chronic leg wound and bacterial infection. This infection is believed to have spread, leading to sepsis and ultimately her death at age 62 in 1689. The symptoms consistent with diabetes, such as extreme thirst, excessive urination, weight loss, and chronic leg wounds, were documented during her lifetime. Doctors in the 17th century did not recognize diabetes as a diagnostic entity, though they noted symptoms like sweet-tasting urine. The researchers' findings complement previous conclusions that she died from an infection, providing a medical explanation for her final illness.